Journals / İstanbul Medical Journal / 2016 / Cilt: 17 - Sayı: 1

Nasal Pseudolymphoma

Nazal Psödolenfoma

Pages
39–42
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nasal Pseudolymphoma etiology, clinical features, diagnosis and therapy is discussed in male patients diagnosed with spon- taneous Pseudolymphoma at the age of 45.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pseudolymphoma (cutaneous lymphoid hyperplasia) caused by various antigenic stimulations in which benign proliferation of polyclonal T and B lymphocytes is observed.
📊
Key Findings & Data:Pseudolymphoma lesions have similar clinical and histopathological findings to those of cutaneous lymphoma.
💡
Conclusion & Impact:Nasal Pseudolymphoma etiology, clinical features, diagnosis and therapy is discussed in male patients diagnosed with spon- taneous Pseudolymphoma at the age of 45.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pseudolymphoma (cutaneous lymphoid hyperplasia) caused by various antigenic stimulations in which benign proliferation of polyclonal T and B lymphocytes is observed. Pseudolymphoma lesions have similar clinical and histopathological findings to those of cutaneous lymphoma. Some studies have reported the conversion potential of pseudolymphomas to cutaneous lymphomas. Nasal Pseudolymphoma etiology, clinical features, diagnosis and therapy is discussed in male patients diagnosed with spon- taneous Pseudolymphoma at the age of 45.

Özet

Psödolenfoma (Kutanöz lenfoid hiperplazi) çeşitli antijenik uyarılar sonucu gelişen, klinik ve histopatolojik olarak kutanöz lenfomalar ile ortak özellikler gösteren, benign T ve B lenfosit poliklonal proliferasyonunun gözlendiği bir hastalıktır. Psödolenfomada, lezyonlar hem klinik hem de histopatolojik olarak kutanöz lenfomaya benzeyebilir. Hatta bazı çalışmalarda Psödolenfomaların kutanöz lenfomaya dönüşüm potansiyeli olduğu da bildirilmiştir. Makalemizde spontan olarak gelişen, Psödolenfoma tanı- sı konulan 45 yaşında bir erkek olgu üzerinden Psödolenfoma etiyolojisi, klinik özellikleri, tanı ve tedavisi tartışılmaktadır.

🔖

Cite This Article

YILDIZ, M., SERVER, E. A., YİĞİT, Ö., LEBLEBİCİ, C. (2022). Nasal Pseudolymphoma. İstanbul Medical Journal, Cilt: 17 - Sayı: 1, 39–42. https://ajindex.com/articles/552119

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Cömert A. Derinin lenfoid hiperplazileri, derinin T hücreli lenfoması, diğer maling lenfomalar ve ilişkili hastalıklar. In: Andrews' Deri Hasta- lıkları Klinik Dermatoloji (çeviren: Aydemir E). James WD, Berger TG, Elston DM. 10 ed. İstanbul: İstanbul Medikal Yayıncılık, 2008; 725-6.
  2. Kulow BF, Cualing H, Steele P, VanHorn J, Breneman JC, Mutasim DF, Breneman DL. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg 2002; 519-28. [CrossRef] Baykal C. Psödolenfoma. Dermatoloji Atlası. 3. Baskı. Nobel Tıp Ki- tapevi, 2012; 1025-35.
  3. Nihal M, Mikkola D, Horvath N, Gilliam AC, Stevens SR, Spiro TP, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol 2003; 34: 617-22. [CrossRef] Gambichler T, Kreuter JA, Stücker M, Kobyletzki GV, Altmeyer P, Hoff- mann K. Guess what Cutaneous lymphoid hyperplasia. Eur J Der- matol 2000; 10: 635-36.
  4. Bouloc A, Delfau-Larue MH, Lenormand B, Meunier F, Wechsler J, Tho- mine E, et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch Dermatol 1999; 135: 168-72. [CrossRef] Bayramgürler D, Aytürk A. İntralezyonel kortikosteroid tedavisi. Turk J Dermatol 2014; 4: 191-6.
  5. Şenol M, Şener S. İntralezyonel kortikosteroid tedavisi. Dermatose 2002; 4: 26-31.
  6. Frooz A, Tehranchi-Nia Z, Ahmed AR. Benefits and risks of intrale- sional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol 1995; 20: 363-70. [CrossRef] Tomar S, Stoll HL, Grassi MA, Cheney R. Treatment of cutaneous pse- udolymphoma with interferon alfa-2b. J Am Acad Dermatol 2009; 60: 172-74. [CrossRef] Zouboulis CC. Principles of cutaneous cryosurgery: an update. Der- matology 1999; 198: 111-7. [CrossRef]